1 recruiting, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow ASXL1 Gene Mutation: new trials by email Literature Review of ASXL1 Gene Mutation trials Research Report on ASXL1 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis Busulfan, Cyclophosphamide, Fludarabine - Anemia, ASXL1 Gene Mutation | Phase 2 | Terminated | University of Utah | 6 | 2018-03-30 | 2022-05-05 |
| ASXL-Related Disorders Natural History Study Bohring-Opitz Syndrome, ASXL1 Gene Mutation | Recruiting | University of California, Los Angeles | 200 | 2017-09-20 | 2025-12-26 |
Anemia (1) · Bohring syndrome (1) · Multiple Myeloma (1) · Primary Myelofibrosis (1) · Thrombocytopenia (1)
Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · Cytopenia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Busulfan (1) · Cyclophosphamide (1) · Hematopoietic Stem Cell Transplantation (1) · Stem Cell Transplantation (1) · fludarabine (1)
University of California, Los Angeles (1) · University of Utah (1)
United States (2)
Bianca Russell, MD (1) · Catherine Lee, MD (1) · Loren Pena, MD, PhD (1) · Vandana Shashi, MD, PhD (1) · Wen-Hann Tan, BMBS (1)